FTS UK public procurement

Pre Market Engagement - NGS HLA Typing Systems and Reagents (NWLP H&I Services)

Imperial College Healthcare NHS Trust

PlanningOCDS ID ocds-h6vhtk-06ac2e
Tender value£3,000,0000 awards · 0 contracts

01 Procurement

Tender overview

Updated 3 June 2026
Buyer
Imperial College Healthcare NHS Trust
Status
Planning
Procurement method
Not supplied
Category
services
CPV classification
Not supplied
Tender period
Not supplied — Not supplied

Description

Pre-Market Engagement Notice – Next Generation Sequencing (NGS) HLA Typing Systems and Reagents North West London Pathology (NWLP), hosted by Imperial College Healthcare NHS Trust, is undertaking pre‑market engagement to gauge market interest and capability ahead of potential future commissioning and procurement activity. This notice is issued for market testing purposes only and does not constitute a commitment to procure, nor does it form part of any formal procurement process. Feedback received will be used to inform commissioning intent, procurement strategy and the development of a future service specification in line with NHS procurement principles of transparency, proportionality, equal treatment and value for money. Background and Context NWLP provides Histocompatibility & Immunogenetics (H&I) services supporting renal transplantation, allogeneic stem cell transplantation and other solid organ transplant programmes across North West London and beyond. High‑resolution HLA typing using Next Generation Sequencing (NGS) is a mandatory clinical requirement and represents the current national and international standard of care. Demand for NGS HLA typing has grown significantly over recent years, driven by expanding transplant programmes and increasing clinical complexity. Current annual reagent expenditure is approximately £600k–£700k, with a projected contract value of £3–3.5m over an expected five‑year term. NWLP is therefore exploring future procurement options to ensure a sustainable, compliant and value‑for‑money solution that supports service resilience, innovation and clinical quality. Suppliers who are interested in this opportunity should complete the attached questionnaire and respond back by July 3rd 2026. To access the opportunity, please use Atamis via contract reference 'C451253'. https://atamis-1928--prospend.vf.force.com/apex/CS_ContractPage?filters=&page=1&Preview=Yes&searchStr=&SearchType=Projects&sortStr=Alphabetical&uid=a07Pz00001e3fTKIAY&sfdcIFrameOrigin=https%3A%2F%2Fatamis-1928.lightning.force.com

i

This page represents one OCDS contracting process. Notices can be revised over time. Values may be estimates, award values or contract values and should be read with their displayed stage and date.

02 Awards and contracts

Published award records

0 shown

No award object is present in this compiled process yet.

03 Organisations

Buyers, suppliers and other parties

1 parties
Buyer

Imperial College Healthcare NHS Trust

St Mary's Hospital, Praed Street, London, UKI32, W2 1NY, United Kingdom

GB-PPON PYMN-2374-JNRY

Companies House links appear only for explicit GB-COH identifiers. BritDB does not create company links from a similar name or address.

04 Provenance

Source for this process

Contains public sector information licensed under the Open Government Licence v3.0. Official external links are available only on the source transition page.